Profile
Dr Chinmay Khandkar
- Interventional and Research Fellow at Royal Prince Alfred Hospital and Concord Hospital
- Clinical Associate Lecturer at the University of Sydney
Dr Chinmay Khandkar is a Cardiologist with a special interest in coronary artery disease and preventive cardiology. He completed his Doctor of Medicine (with Distinction) at the University of New South Wales, and holds a Master of Medicine (Clinical Epidemiology) from the University of Sydney. He attained his FRACP after completing his cardiology training at Royal Prince Alfred Hospital. He has completed the American Society of Echocardiography of National Board Certification Examination. He also serves as a Clinical Associate Lecturer at the University of Sydney.
Dr Khandkar is a recipient of both the NHMRC and Heart Foundation scholarships for his PhD currently underway at the University of Sydney. His research focuses on diagnosing and managing non-obstructive coronary disease syndromes.
Dr Khandkar provides comprehensive cardiac care with a holistic and compassionate approach.
- Coronary artery disease syndromes, including microvascular disease and coronary artery spasm
Peer-reviewed Publications
2021 Khandkar C, Patel S., Galougahi KK. Intravascular imaging and novel techniques to disrupt severely calcified lesions. Advances in Interventional Cardiology. 2021; 17(4): 337-339.
2021 Khandkar C, Vaidya K, Patel S. Low Bone Mineral Density and Coronary Artery Disease. A Systematic Review and Meta-Analysis. IJC Heart and Vasculature. 2021; 37:100891
– Also presented as poster at the Cardiac Society of Australia and New Zealand Annual Scientific Meeting 2021
2021 Khandkar C, Madhava MV, Weaver JC, Celermajer DS, Galougahi KK. Atherothrombosis in Acute Coronary Syndromes – From Mechanistic Insights to Targeted Therapies. Cells. 2021; 10(4), 865.
2021 Khandkar C, Patel S, Arnott C, Procedural Volumes in the era of COVID: The Risk versus Benefit Trade-Off. Heart Lung Circ. 2021. 30(10): 1430-1432.
2021 Tucker BJ, Vaidya K, Karup R, Khandkar C, Barraclough J, Misra A, Kavurma M, Martinez G, Rye K, Cochran BJ, Patel S. Colchicine inhibits neutrophil extracellular trap formation in patients with acute coronary syndrome after percutaneous coronary intervention. J Am Heart Assoc. 2021; 10(1):e018993:
2020 Khandkar C^, Vaidya K, Penglase R, Cai K, Shin JJ, Hunyor I, Keech A, McGill N. A rare case of infiltrative cardiomyopathy secondary to scleromyxedema. Internal Medicine Journal. 2020; 50(1): 127-128
– Also presented as poster at the Cardiac Society of Australia and New Zealand Annual Scientific Meeting 2018
2019 Khandkar C, Vaidya K, Patel S. Colchicine for Stroke Prevention: A Systematic Review and Metaanalysis. Clinical Therapeutics. 2019; 41(3) 582-590.
2018 Vaidya K, Khandkar C, Celermajer D. Non-Surgical Closure of Patent Ovale Foramen (PFO) – an update on a still unresolved issue. Cardiovascular Diagnostics and Therapy. 2018; 8(6): 739-753.
2018 Kent NB, Liang SS, Phillips S, Smith NA, Khandkar C, Eikermann M, Stewart PA. Therapeutic doses of neostigmine, depolarising neuromuscular blockade and muscle weakness in awake volunteers; A double blind, placebo controlled, randomised volunteer study. Anaesthesia. 2018; 73(9): 1079-89.
2016 Khandkar C, Liang S, Phillips S, Lee CY, Stewart PA^. Comparison of kinemyography and electromyography during spontaneous recovery from non-depolarising neuromuscular blockade. Anaesth Intensive Care. 2016; 44(6):745-751.
– Also presented as oral presentation at Australian Society of Anaesthetists National Scientific Congress, 2014
2015 Khandkar C^, Harrington Z, Jelfs PJ, Sintchenko V., Dobler CC. Epidemiology of Peripheral Lymph Node Tuberculosis and Genotyping of M. tuberculosis Strains: A Case-Control Study. PLOS One. 2015; 10(7): e0132400.
– Also presented as poster at the Thoracic Society of Australian and New Zealand Annual Scientific Meeting, 2014
– Also presented as oral presentation at Ingham Research Showcase, November 2013
Other Publications
2024 Khandkar C, Fuclher J, Patel S, Keech, A. Treatment of vulnerable atherosclerotic plaques. the PREVENT trial. 2024. The Lancet. 404 (10465): 1811-12.
2024 Rehan R, Khandkar C^, Wong CCY, Weaver J, Jain P, Adams MR, Tremmel J, Yong A. TCT – 856 Evaluating the Diagnostic Validity of Incremental Acetylcholine Doses for Inducing Coronary Artery Spasm in Angina with Non-Obstructive Coronary Arteries. 2024. J Am Coll Cardiol. 84(18):B352
– Oral presentation at TCT 2024 in Washington DC.
2024 Sawant S, Freedman G, Terrett S, Garcia A, Khandkar C, Sivashanmugarajah A, Baumann A. Abstract 4138813: The Use of Direct Oral Anticoagulants for Valvular Atrial Fibrillation in Central Australia. Circulation. 150.Supp 1.
2016 Kent NB, Liang SS, Khandkar C, Phillips S, Smith N, Eikermann M, Stewart PA. Neostigmine induces a restrictive ventilatory impairment pattern in awake healthy volunteers: a randomised controlled study. 2017. Anaesth Intensitve Care. 45(2): 263.
2016 Badie TN^, Nindra U, Khandkar C, Assad J, French JK, Juergens CP. Bleeding and major adverse cardiac events in non-cardiac surgery, within 2 years post percutaneous coronary intervention. Euro PCR 2016